Semi-Annual Consolidated Statement Of Changes In Equity

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7608021

Concept As at
2021-06-30
2021-04-01 to
2021-06-30
Semi-annual consolidated statement of changes in equity
Statement of changes in equity
Net assets
45,313,000,000 JPY
Changes during period
Profit (loss) attributable to owners of parent
1,098,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.